{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in parkin account for approximately 50% of all autosomal recessive juvenile Parkinson's disease (ARJP) cases. Parkin is a multidomain E3 ligase essential in the ubiquitination pathway, and mutations in the ubiquitin-like domain (Ubld) result in impaired E3 ligase activity and decreased protein stability.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as impaired E3 ligase activity and protein stability due to mutations in the parkin Ubld, which is relevant to ARJP pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses urea unfolding experiments monitored by circular dichroism (CD) spectropolarimetry and NMR spectroscopy to assess the structural stability and folding of the parkin Ubld with the R42P mutation.",
          "judgment": "Yes",
          "reasoning": "CD spectropolarimetry and NMR spectroscopy are established methods to evaluate protein stability and structure, which are directly relevant to the disease mechanism of impaired ligase activity and protein stability in ARJP.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compares the parkin Ubld R42P mutant with wild-type parkin Ubld and ubiquitin using CD spectropolarimetry and NMR. Unfolding experiments were conducted in duplicate, and wild-type proteins served as negative controls.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin Ubld and ubiquitin serve as negative controls, and the paper mentions experiments conducted in duplicate, indicating replicates were used.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study includes the K48A mutation as another variant tested alongside R42P, but no known pathogenic or benign variants with established P/LP or B/LB criteria independent of PS3/BS3 are explicitly used as controls.",
          "judgment": "No",
          "reasoning": "While another mutation (K48A) was tested, there is no mention of known pathogenic or benign variants with established classifications independent of functional evidence used as controls.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for PARK2 R42P supports pathogenicity at a supporting level (PS3_supporting) due to the demonstrated global unfolding of the Ubld, which likely contributes to rapid degradation and loss of E3 ligase activity. However, the lack of variant controls with established classifications limits the strength to supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": "48"
        },
        "variant_string_id": "PARK2 K48A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in parkin account for approximately 50% of all autosomal recessive juvenile Parkinson's disease (ARJP) cases. Parkin is a multidomain E3 ligase essential in the ubiquitination pathway, and mutations in the ubiquitin-like domain (Ubld) result in impaired E3 ligase activity and decreased protein stability.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as impaired E3 ligase activity and protein stability due to mutations in the parkin Ubld, relevant to ARJP pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses urea unfolding experiments monitored by circular dichroism (CD) spectropolarimetry to assess the structural stability of the parkin Ubld with the K48A mutation.",
          "judgment": "Yes",
          "reasoning": "CD spectropolarimetry is an established method to evaluate protein stability, which is relevant to the disease mechanism of impaired ligase activity and protein stability in ARJP.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compares the parkin Ubld K48A mutant with wild-type parkin Ubld and ubiquitin using CD spectropolarimetry. Unfolding experiments were conducted in duplicate, and wild-type proteins served as negative controls.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin Ubld and ubiquitin serve as negative controls, and the paper mentions experiments conducted in duplicate, indicating replicates were used.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study includes the R42P mutation as another variant tested alongside K48A, but no known pathogenic or benign variants with established P/LP or B/LB criteria independent of PS3/BS3 are explicitly used as controls.",
          "judgment": "No",
          "reasoning": "While another mutation (R42P) was tested, there is no mention of known pathogenic or benign variants with established classifications independent of functional evidence used as controls.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for PARK2 K48A supports pathogenicity at a supporting level (PS3_supporting) due to minor effects on protein stability but potential disruption of interactions with the proteasome. The lack of variant controls with established classifications limits the strength to supporting."
    }
  ]
}